Latest news
FDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children - Patient Care OnlinePatient Care Online · Sat, 08 Aug 2026 02:54:59 GMTVials for an SMA treatment candidate await packaging as FDA review shifts - Stock TitanStock Titan · Fri, 07 Aug 2026 20:20:00 GMTNRx Pharmaceuticals to Host Conference Call on FDA First-Cycle Review of Preservative-Free Ketamine ANDA - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:10:00 GMTNRx to Discuss Preservative-Free Ketamine Approval Path Aug. 10 - Stock TitanStock Titan · Fri, 07 Aug 2026 20:01:00 GMTUS FDA to hold advisory meeting to review Grail's multi-cancer test - ReutersReuters · Fri, 07 Aug 2026 18:51:34 GMTGRAIL Bets Its Galleri Panel Will Set The FDA Bar For Future MCEDs - insights.citeline.cominsights.citeline.com · Fri, 07 Aug 2026 12:26:38 GMTA vial used in products that shipped 11.9M doses remains in NRx's FDA review - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTAn FDA Panel Just Backed 6 Peptides—Here’s What to Know - EatingWellEatingWell · Thu, 06 Aug 2026 22:01:36 GMT